Healthcare
Health
Medical

DaVita

$48.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.10 (-2.23%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell DaVita and other stocks, options, ETFs, and crypto commission-free!

About

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services; and Other-Ancillary Services and Strategic Initiatives. Read More The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

Employees
77,700
Headquarters
Denver, Colorado
Founded
1994
Market Cap
8.20B
Price-Earnings Ratio
67.32
Dividend Yield
0.00
Average Volume
1.61M
High Today
$48.98
Low Today
$47.61
Open Price
$48.98
Volume
519.42K
52 Week High
$79.11
52 Week Low
$47.61

Collections

Healthcare
Health
Medical
US
North America

News

Seeking AlphaMay 20

Dear Mr. Buffett, DaVita Is Going To Need A Check From You

The CEO is stepping down at a critical time for DaVita. An FTC official is saying that it must “push the envelope” in health. I am continuing to hold my price target of bailout or bankruptcy, I don't think this system is remotely sustainable. There is a lot to unpack from the Q1 and recent events. One, is that the DMG deal has yet to close, with the CEO outbound at a critical time. Two, is that charitable assistance is still an outstanding issue. The DMG Sale This sale has been going on since Dec. 5, 201...

203
Yahoo FinanceMay 16

Here's Why You Should Retain DaVita in Your Portfolio

DaVita Inc. DVA is gaining prominence in the MedTech space, courtesy of its incessant efforts to upgrade services, global expansion initiatives and acquisitions. The company has a market capitalization of approximately $8.36 billion. The stock currently carries a Zacks Rank #3 (Hold). Price Performance Shares of DaVita have lost 2.4%, against the industry’s growth of 5.4% on a year-to-date basis. Further, the stock compares unfavorably with the S&P 500 Index’s rally of 12.3%. What’s Deterring ...

89
Yahoo FinanceMay 15

DaVita Reports on 2018 Corporate Social Responsibility Initiatives

Company highlights achievements in patient care, community growth and sustainability DENVER, May 15, 2019 /PRNewswire/ -- DaVita Inc. (DVA), a leading provider of kidney care services in the United States, today released its annual Community Care report, highlighting its 2018 clinical and community-building achievements. "The foundation of what we do is about caring for our patients, each other and the world," said Javier Rodriguez, CEO for DaVita Kidney Care. "We have and will continue to push and innova...

14

Earnings

$0.56
$0.72
$0.89
$1.05
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 31, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.